TG Therapeutics | TGTX - Loan Capital


TG Therapeutics reported $245.64M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Amgen USD 50B 2.43B Dec/2025
Ardelyx USD 202.83M 696K Dec/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
Bayer EUR 31.83B 877M Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Curis USD 29.43M 10.69M Jun/2024
Gilead Sciences USD 22.13B 6M Dec/2025
Infinity Pharmaceuticals USD 0 0 Jun/2022
J&J USD 37.53B 1.91B Mar/2026
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Novavax USD 246.3M 200K Dec/2025
PTC Therapeutics USD 2.03B 193.22M Dec/2025
Puma Biotechnology USD 10.87M 222K Jun/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
TG Therapeutics USD 245.64M 305K Dec/2025
Verastem USD 81.33M 31.01M Dec/2025
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025